Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Dec 4;35(48 Pt A):6575-6581.
doi: 10.1016/j.vaccine.2017.03.103. Epub 2017 May 4.

Immunization in pregnancy clinical research in low- and middle-income countries - Study design, regulatory and safety considerations

Sonali Kochhar  1 , Jan Bonhoeffer  2 , Christine E Jones  3 , Flor M Muñoz  4 , Angel Honrado  5 , Jorgen Bauwens  6 , Ajoke Sobanjo-Ter Meulen  7 , Steven Hirschfeld  8
Affiliations

Immunization in pregnancy clinical research in low- and middle-income countries - Study design, regulatory and safety considerations

Sonali Kochhar et al. Vaccine. .

Abstract

Immunization of pregnant women is a promising public health strategy to reduce morbidity and mortality among both the mothers and their infants. Establishing safety and efficacy of vaccines generally uses a hybrid design between a conventional interventional study and an observational study that requires enrolling thousands of study participants to detect an unknown number of uncommon events. Historically, enrollment of pregnant women in clinical research studies encountered many barriers based on risk aversion, lack of knowledge, and regulatory ambiguity. Conducting research enrolling pregnant women in low- and middle-income countries can have additional factors to address such as limited availability of baseline epidemiologic data on disease burden and maternal and neonatal outcomes during and after pregnancy; challenges in recruiting and retaining pregnant women in research studies, variability in applying and interpreting assessment methods, and variability in locally acceptable and available infrastructure. Some measures to address these challenges include adjustment of study design, tailoring recruitment, consent process, retention strategies, operational and logistical processes, and the use of definitions and data collection methods that will align with efforts globally.

Keywords: Antenatal care; Clinical trials; Developing country; Ethics; Immunization; Infectious diseases; International health; Low and middle income country; Pregnancy; Pregnant women; Public health; Regulatory; Research; Safety; Study design; Vaccination; Vaccines.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Jamieson Denise J., Theiler Regan N., Rasmussen Sonja A. Emerging infections and pregnancy. Emerg Infect Dis. 2006;12(11):1638–1643. - PMC - PubMed
    1. Swamy Geeta K., Heine R. Phillips. Vaccinations for pregnant women. Obstet Gynecol. 2015;125(1):212–226. - PMC - PubMed
    1. Vaccines against influenza and pertussis – WHO position papers <http://www.who.int/wer/2012/wer8747.pdf>, <http://www.who.int/wer/2015/wer9035.pdf-> [accessed on Feb 24, 2017].
    1. Wilson R.J., Paterson P., Jarrett C., Larson H.J. Understanding factors influencing vaccination acceptance during pregnancy globally: a literature review. Vaccine. 2015;33(47):6420–6429. - PubMed
    1. Safety of Immunization during Pregnancy – a review of the evidence. Global Advisory Committee on Vaccine Safety. <http://www.who.int/vaccine_safety/publications/safety_pregnancy_nov2014.pdf> [accessed on 24 Feb 2017].